Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / Uganda / Gilead Sciences

Uganda & Gilead Sciences

2 shared events · Importance 9 · Last updated Jul 04, 2026

Importance
9
Shared Events
2
Actions
0
Sentiment
0.125
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (2)
42
Tech
WHO Lists Bundibugyo Ebola Test
Uganda: Uganda has reported cases of the Bundibugyo ebolavirus outbreak, linked to cross-border transmission from the Democratic Republic of the Congo. The new diagnostic test will aid Uganda's response efforts, although no new cases have been reported there since June 21.
Gilead Sciences: Gilead Sciences' antiviral drug remdesivir is being evaluated in combination with Mapp Biopharmaceutical's MBP134 antibody in a treatment trial for the Bundibugyo Ebola outbreak.
Jul 02, 2026 · 8 articles
37
Tech
Ebola Treatment Trial Begins DRC
Uganda: Uganda has confirmed cases linked to the Ebola outbreak in the Democratic Republic of the Congo, highlighting the risk of cross-border transmission.
Gilead Sciences: Gilead Sciences is the developer of remdesivir, one of the antiviral drugs being evaluated in the clinical trial for Ebola. The company has donated doses of the drug for the study.
Apr 20, 2026 · 67 articles
NEWSDESK
Explore this relationship live

Track how Uganda and Gilead Sciences interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.